ARTICLE | Clinical News
Generx cardionovo alferminogene tadenovec: Phase III started
March 26, 2012 7:00 AM UTC
Cardium began the open-label, Russian Phase III ASPIRE trial to evaluate Generx administered through a standard cardiac infusion catheter in about 100 patients with myocardial ischemia due to coronary...